文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2000 年至 2015 年中国原发性骨恶性肿瘤发病、死亡及变化趋势分析。

Primary malignant bone tumors incidence, mortality, and trends in China from 2000 to 2015.

机构信息

Inner Mongolia Integrative Center for Disease Control and Prevention, Hohhot, Inner Mongolia Autonomous Region 010031, China.

Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

出版信息

Chin Med J (Engl). 2023 Sep 5;136(17):2037-2043. doi: 10.1097/CM9.0000000000002547.


DOI:10.1097/CM9.0000000000002547
PMID:37667432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10476727/
Abstract

BACKGROUND: Primary malignant bone tumors are uncommon, and their epidemiological features are rarely reported. We aimed to study the incidence and death characteristics of bone tumors from 2000 to 2015. METHODS: Population-based cancer registries submitted registry data to National Central Cancer Registry of China (NCCRC). The data collected from 501 local cancer registries in China were assessed using NCCRC screening methods and criteria. Incidence and mortality rates of primary bone tumor were stratified by age group, gender, and area. Age-standardized incidence and mortality rates were adjusted using the Chinese standard population in 2000 and Segi's world population. The annual percentage change (APC) in rate was calculated using the Joinpoint Regression Program. RESULTS: Data from 368 registries met quality control criteria, of which 134 and 234 were from urban and rural areas, respectively. The data covered 309,553,499 persons. The crude incidence, age-standardized incidence, and crude mortality rates were 1.77, 1.35, and 1.31 per 100,000, respectively. Incidence and mortality rates were higher in males than those in females; they showed downward trends, with declines of 2.2% and 4.8% per year, respectively, and the rates in urban areas were lower than those in rural areas. Significant declining trends were observed in urban areas. Stable trends were seen in rural areas during 2000 to 2007, followed by downward trends. Age-specific incidence and mortality rates showed stable trends in the age group of 0 to 19 years, and downward trends in the age group elder than 19 years. CONCLUSIONS: The incidence and mortality rates of primary malignant bone tumors in rural areas were higher compared to those in urban areas. Targeted prevention measures are required to monitor and control bone tumor incidence and improve the quality of life of affected patients. This research can provide a scientific basis for the prevention and control of bone tumors, as well as basic information for follow-up research.

摘要

背景:原发性骨恶性肿瘤较为少见,其流行病学特征鲜有报道。本研究旨在分析 2000 年至 2015 年骨肿瘤的发病和死亡特征。

方法:人口肿瘤登记处向国家癌症中心(NCCRC)上报登记数据。通过 NCCRC 筛查方法和标准,对中国 501 个肿瘤登记处的数据进行评估。按年龄组、性别和地区分层分析原发性骨肿瘤的发病率和死亡率。采用 2000 年中国标准人口和 Segi 世界人口校正发病率和死亡率标化率。应用 Joinpoint 回归程序计算发病率的年度变化百分比(APC)。

结果:符合质量控制标准的登记处数据共 368 个,其中城市和农村地区分别有 134 个和 234 个。数据覆盖 309,553,499 人。粗发病率、年龄标化发病率和粗死亡率分别为 1.77/100,000、1.35/100,000 和 1.31/100,000。男性的发病率和死亡率均高于女性,且呈下降趋势,每年分别下降 2.2%和 4.8%,城市地区的发病率和死亡率均低于农村地区。城市地区发病率呈显著下降趋势,农村地区 2000 年至 2007 年呈稳定趋势,随后呈下降趋势。0 岁至 19 岁年龄组的发病率和死亡率呈稳定趋势,19 岁以上年龄组的发病率和死亡率呈下降趋势。

结论:农村地区原发性恶性骨肿瘤的发病率和死亡率均高于城市地区。需要采取有针对性的预防措施来监测和控制骨肿瘤的发病,提高患者的生活质量。本研究可为骨肿瘤的防治提供科学依据,为后续研究提供基础信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/10476727/95b6da67cd1e/cm9-136-2037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/10476727/64d5bba615e1/cm9-136-2037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/10476727/95b6da67cd1e/cm9-136-2037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/10476727/64d5bba615e1/cm9-136-2037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/10476727/95b6da67cd1e/cm9-136-2037-g002.jpg

相似文献

[1]
Primary malignant bone tumors incidence, mortality, and trends in China from 2000 to 2015.

Chin Med J (Engl). 2023-9-5

[2]
[Incidence and mortality of stomach cancer in China, 2013].

Zhonghua Zhong Liu Za Zhi. 2017-7-23

[3]
[Estimation on the incidence and mortality of kidney cancer in China, in 2014].

Zhonghua Liu Xing Bing Xue Za Zhi. 2018-10-10

[4]
[Report of cancer epidemiology in China, 2015].

Zhonghua Zhong Liu Za Zhi. 2019-1-23

[5]
[Incidence and mortality of bladder cancer in China, 2014].

Zhonghua Zhong Liu Za Zhi. 2018-9-23

[6]
[Cancer statistics in China, 2016].

Zhonghua Zhong Liu Za Zhi. 2023-3-23

[7]
[The incidence and mortality of lung cancer in China, 2014].

Zhonghua Zhong Liu Za Zhi. 2018-11-23

[8]
Colorectal cancer incidence and mortality in China, 2010.

Asian Pac J Cancer Prev. 2014

[9]
[Incidence and mortality of female breast cancer in China, 2014].

Zhonghua Zhong Liu Za Zhi. 2018-3-23

[10]
[Incidence and mortality of laryngeal cancer in China, 2014].

Zhonghua Zhong Liu Za Zhi. 2018-10-23

引用本文的文献

[1]
Burden of malignant neoplasm of bone and articular cartilage from 1990 to 2021 and its predictions to 2030 in China compared with world.

Front Oncol. 2025-8-21

[2]
Comparative assessment of sarcopenia screening tools for patients with bone tumors: insights for enhanced clinical application.

Front Nutr. 2025-8-4

[3]
Global, Regional, and National Burden and Trends of Soft Tissue and Other Extraosseous Sarcomas From 1990 to 2021.

Cancer Control. 2025

[4]
Functional Outcomes and Activity Levels in Patients After Internal Hemipelvectomy for Primary Sarcoma Involving the Bony Pelvis.

Diagnostics (Basel). 2025-6-6

[5]
Development and clinical application of extendable prostheses in limb salvage surgery for primary malignant bone tumours in children : a systematic review of functional outcomes and complications.

Bone Joint Res. 2025-6-25

[6]
Global bone cancer incidence and death rate analysis at 40 years.

Discov Oncol. 2025-6-13

[7]
Burden and projections of malignant neoplasm of bone and articular cartilage in China: an analysis for the global burden of disease study 2021.

BMC Musculoskelet Disord. 2025-5-24

[8]
A novel perspective on bone tumors: advances in organoid research.

Front Pharmacol. 2025-4-8

[9]
PLGA-based drug delivery systems in treating bone tumors.

Front Bioeng Biotechnol. 2023-6-1

本文引用的文献

[1]
Cancer registration in China and its role in cancer prevention and control.

Lancet Oncol. 2020-7

[2]
Cancer burden of major cancers in China: A need for sustainable actions.

Cancer Commun (Lond). 2020-5

[3]
The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis.

Cells. 2020-4-15

[4]
Incidence and mortality of laryngeal cancer in China, 2015.

Chin J Cancer Res. 2020-2

[5]
Incidence and mortality of corpus uteri cancer in China, 20082012.

Chin J Cancer Res. 2019-6

[6]
Incidence and mortality of bone cancer among children, adolescents and young adults of Brazil.

Clinics (Sao Paulo). 2019-5-13

[7]
Incidence and mortality of primary bone cancers in China, 2014.

Chin J Cancer Res. 2019-2

[8]
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2018-10-1

[9]
Impact of the New Cooperative Medical Scheme on the Rural Residents' Hospitalization Medical Expenses: A Five-Year Survey Study for the Jiangxi Province in China.

Int J Environ Res Public Health. 2018-6-29

[10]
Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries.

Lancet Glob Health. 2018-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索